Oxygen News and Research

RSS

AI technology can assess COVID-19 severity with a promising degree of accuracy

Artificial intelligence (AI) technology developed by researchers at the University of Waterloo is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy.

29 May 2021

Blood oxygen levels may explain why memory loss is an early symptom of Alzheimer's disease

In a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for why the area, commonly referred to as 'the brain's memory center', is vulnerable to damage and degeneration, a precursor to Alzheimer's disease.

29 May 2021

Methylene Blue could replace current sunscreen components to protect human skin and the environment

New research using a sunscreen based on Methylene Blue has proven effective in protecting from UV irradiation as well as being safe for coral reefs.

28 May 2021

Melatonin prevents kidney damage caused by metabolic complications of obesity

Scientists from the University of Granada (UGR), the Hospital Universitario La Paz (Madrid), and the University of Texas (USA) have taken an important step in the fight against kidney damage and its progression towards kidney failure, which is closely related to diabesity (obesity and its type 2 diabetes) and its complications.

27 May 2021

Adults with obsessive compulsive disorder face higher risk of ischemic stroke

Adults who have obsessive-compulsive disorder (OCD) were more than three times as likely to have an ischemic stroke later in life compared to adults who do not have OCD, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

27 May 2021

Beckman Coulter Life Sciences launches next-generation Biolector XT Microbioreactor

Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new BioLector XT Microbioreactor which features the highest flexibility, enabling more applications in the BioLector series of instruments from m2p-labs, part of the Beckman Coulter Life Sciences’ Biotechnology Business Unit since November 2020.

From Beckman Coulter Life Sciences - Flow Cytometry 27 May 2021

Enough to wreck their rest: $10,322 for a sleep study

José Mendoza's snoring was bad — but the silence when he stopped breathing was even worse for his wife, Nancy.

27 May 2021

OCD linked to higher stroke risk in later life

New findings indicate that the risk of developing ischemic strokes is increased in people with obsessive-compulsive disorder (OCD).

27 May 2021

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

COVID-19 was initially described as lung inflammation, or pneumonia, in older adults. However, we now know that SARS-CoV-2 infections can cause a wide range of symptoms in people of all ages, ranging from no symptoms at all to systemic inflammation and even death.

27 May 2021

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Late last year, Janet Yetenekian was one of the thousands of people in Southern California whose case of covid-19 was serious enough to send her to the hospital.

26 May 2021

Altered blood flow in the brain may cause symptoms of Parkinson's disease

Patients who suffer from REM sleep behavior disorder have altered blood flow in the brain, which can lead to a lack of oxygen in the brain tissue. In the long term, this may cause symptoms of Parkinson's disease. This is shown by research from Aarhus University and Aarhus University Hospital.

26 May 2021

Researchers identify mechanism that may lead to new therapies for strokes, brain injuries

In a surprising discovery, researchers at Massachusetts General Hospital (MGH) identified a mechanism that protects the brain from the effects of hypoxia, a potentially lethal deprivation of oxygen.

26 May 2021

DEFINE: Trial designed to test repurposed treatments in patients with COVID-19

A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.

25 May 2021

Superoxide produced in the inner ear cochlea causes major types of acquired hearing loss

Professor UEYAMA Takehiko (Biosignal Research Center, Kobe University) and the inner ear research group (Kyoto Prefectural University of Medicine) have identified the cell types in the inner ear cochlea responsible for the production of superoxide (Nox3-expressing cells).

25 May 2021

Could saffron be an effective supplement for helping manage COVID-19?

A new study, published in the journal Cell Press, explores the potential use of saffron (Crocus sativus L.) as a drug supplement for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).

24 May 2021